EnteroBiotix
Biotechnology; Clinical Trials; Life Science
EnteroBiotix has raised €42M across 3 funding rounds from 7 investors, most recently a round in May 2026. Based in Edinburgh, UK; founded 2017; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€42M
€42,459,786
Funding rounds
3
Investors
7
distinct backers
Active since
2019-04
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDEnteroBiotix — funding by year — interactive chart.
Data table
| EnteroBiotix — funding by year | |
|---|---|
| 2019 | €2.3M |
| 2021 | €18M |
| 2026 | €22M |
Signals
High confidenceRaise-next likelihood30
base rate 30% for Other
- ▼ Raised very recently
- ▲ Up-round momentum
Exit likelihood20
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 9y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-04 | Other | €22M | Existing investors,Scottish National Investment Bank,Thairm Bio | View deal → |
| 2021-09-07 | Series A | €18M | Kineticos Ventures,Scottish Enterprise,SIS Ventures,Thairm Bio | View deal → |
| 2019-04-01 | Seed | €2.3M | Equity Gap | View deal → |